Quantification of indirect pathway inhibition by the adenosine A 2a antagonist SYN115 in Parkinson disease

Authors

Kevin J. Black, Washington University School of Medicine in St. LouisFollow
Jonathan M. Koller, Washington University School of Medicine in St. Louis
Meghan C. Campbell, Washington University School of Medicine in St. LouisFollow
Debra A. Gusnard, Washington University School of Medicine in St. Louis
Stephen I. Bandak, Synosia Therapeutics

Journal

The Journal of Neuroscience

Publication Date

2010

Volume

30

Issue

48

Inclusive Pages

16284-16292

Document Type

Open Access Publication

DOI

10.1523/JNEUROSCI.2590-10.2010

Rights and Permissions

Black, Kevin J., et al. Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease. The Journal of Neuroscience, 1 December 2010, 30(48):16284-16292; doi:10.1523/JNEUROSCI.2590-10.2010

Recommended Citation

Black, Kevin J.; Koller, Jonathan M.; Campbell, Meghan C.; Gusnard, Debra A.; and Bandak, Stephen I., "Quantification of indirect pathway inhibition by the adenosine A 2a antagonist SYN115 in Parkinson disease." The Journal of Neuroscience. 30, 48. 16284-16292. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/230